en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
2/2010
vol. 48
 
Share:
Share:
more
 
 
abstract:
Original paper

Growth hormone therapy in growth retardation in juvenile idiopathic arthritis

Ewa Gniadek
,
Jacek Postępski

Reumatologia 2010; 48, 2: 112–120
Online publish date: 2010/05/14
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Growth retardation is a major problem in children suffering from juvenile idiopathic arthritis (JIA), especially those with a systemic and polyarticular course of the disease.
The article reviews the current literature on clinical studies concerned with growth retardation and growth hormone (GH) therapy in children with JIA.
Growth retardation is a result of persistent inflammation in JIA and may be intensified by the adverse effects of glucocorticoid therapy. Current treatment strategies in JIA do not always stop growth retardation, in which case GH therapy is recommended. The best results are achieved when GH is applied before severe growth retardation has appeared.
keywords:

juvenile idiopathic arthritis, growth hormone, growth retardation







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.